voncento
csl behring gmbh - Ľudský koagulačný faktor viii, ľudské von willebrand faktor - hemophilia a; von willebrand diseases - blood coagulation factors, von willebrand factor and coagulation factor viii in combination, antihemorrhagics - von willebrand ochorenia (vwd)profylaxii a liečbe krvácania alebo chirurgického krvácania u pacientov s vwd, keď desmopressin (ddavp) liečbou je neúčinné, alebo kontraindikovaný. haemophilia a (vrodený faktor viii nedostatok)profylaxii a liečbe krvácania u pacientov s haemophilia a.
cevenfacta
laboratoire francais du fractionnement et des biotechnologies - eptacog beta (activated) - hemophilia a; hemophilia b - antihemoragiká - cevenfacta is indicated in adults and adolescents (12 years of age and older) for the treatment of bleeding episodes and for the prevention of bleeding in those undergoing surgery or invasive procedures in the following patient groups:in patients with congenital haemophilia with high-responding inhibitors to coagulation factors viii or ix (i. ≥5 bethesda units (bu)); in patients with congenital haemophilia with low titre inhibitors (bu.
octanine f 250 i.u.
octapharma pharmazeutika produktionsges.m.b.h., rakúsko - koagulačný faktor ix - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
prothromplex nf 600 iu
baxalta innovations gmbh, rakúsko - koagulačné faktory ix, ii, vii a x v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
fanhdi 25 iu/ml
instituto grifols, s.a., Španielsko - koagulačný faktor viii a von willebrandov faktor v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
fanhdi 50 iu/ml
instituto grifols, s.a., Španielsko - koagulačný faktor viii a von willebrandov faktor v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
fanhdi 100 iu/ml
instituto grifols, s.a., Španielsko - koagulačný faktor viii a von willebrandov faktor v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
fanhdi 100 iu/ml
instituto grifols, s.a., Španielsko - koagulačný faktor viii a von willebrandov faktor v kombinácii - 16 - anticoagulantia (fibrinolytica, antifibrinol.)
coagadex
bpl bioproducts laboratory gmbh - Ľudský koagulačný faktor x - nedostatok faktora x - vitamin k and other hemostatics, antihemorrhagics, coagulation factor x - coagadex je indikovaný na liečbu a profylaxiu krvácavých epizód a na perioperačnú liečbu u pacientov s dedičným nedostatkom faktora x. coagadex je uvedené vo všetkých vekových skupinách.
kymriah
novartis europharm limited - tisagenlecleucel - precursor b-cell lymphoblastic leukemia-lymphoma; lymphoma, large b-cell, diffuse - iné antineoplastické látky - kymriah is indicated for the treatment of:• paediatric and young adult patients up to and including 25 years of age with b cell acute lymphoblastic leukaemia (all) that is refractory, in relapse post transplant or in second or later relapse. • adult patients with relapsed or refractory diffuse large b cell lymphoma (dlbcl) after two or more lines of systemic therapy. • adult patients with relapsed or refractory follicular lymphoma (fl) after two or more lines of systemic therapy.